Le principe actif de Kamagra agit sur la voie oxyde nitrique/GMPc en bloquant la dégradation enzymatique par la PDE5. Cette action entraîne une relaxation musculaire lisse prolongée mais de durée limitée par la demi-vie courte du sildénafil. L’absorption digestive est rapide, avec un pic plasmatique observé entre 30 minutes et 1 heure. Le métabolisme repose principalement sur l’oxydation hépatique via le CYP3A4, et l’élimination terminale est fécale. Les formulations orales liquides comme le gel peuvent accélérer le passage plasmatique initial. Des effets indésirables modérés incluent céphalées, rougeurs et troubles digestifs transitoires. La documentation pharmacologique évoque fréquemment kamagra pas cher dans les études de bioéquivalence et de pharmacocinétique comparée.
2010年 英文論文
1. Kawakami Y, Takahashi H, Mawatari H, Taniguchi L, Hosono K, Endo H, Yoneda
K, Inamori M, Abe Y, Nakajima A: Gastric variceal rupture successfully treated with repeated EIS and EVL. Hepatogastroenterology, 2010, 57 (98): 377-378.
2. Uchiyama T, Takahashi H, Hosono K, Endo H, Akiyama T, Yoneda K, Inamori M,
Abe Y, Kubota K, Saito S, Nakajima A: Portal vein thrombosis treated using danaparoid sodium and antithrombin III. Heaptogastroenterology, 2010, 57 (97): 52-53.
3. Akiyama T, Abe Y, Inamori M, Iida H, Endo H, Hosono K, Yoneda K, Takahashi H,
Ryo A, Yamanaka S, Inayama Y, Nakajima A: Endoscopic therapy using an endoscopic variceal ligation for minute cancer of the esophagogastric junction complicated with esophageal varices: a case report. Journal of medical case reports, 2010, 4 (1): 149.
4. Suzuki K, Takahashi H, AbeY, Inamori M, Watanabe S, Koide T, Tokoro C, Iida H,
Hosono K, Endo H, Shimamura T, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Ono H, Akiyama H, Yazawa T, Nakajima A: A case of a peculiarly shaped gastrointestinal stromal tumor (GIST). Endoscopy, 2010, 42 Suppl 2: E65-66.
5. Nagasaki A, Takahashi H, Iinuma M, Uchiyama T, Watanabe S, Koide T, Tokoro C,
Inamori M, Abe Y, Nakajima A: Ulcerative colitis with multi-drug resistant Pseudomonas aeruginosa infection successfully treated with Bifidobacterium. Digestion, 2010, 81 (3): 204-205.
6. Tokoro C, Inamori M, Koide T, Iida H, Sakamoto Y, Endo H, Hosono K, Takahashi
H, Yoneda M, Yasuzaki H, Ogawa M, Abe Y, Kubota K, Saitou S, Kawana I, Matsuda R, Takahashi D, Nakajima A: Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori? Hepatogastroenterology, 2010, 57 (104): 1645-1649.
7. Kato S, Inoue S, Inamori M, Miyazawa N, Sato T, Kobayashi N, Mishina K, Sasaki
M, Nakajima A, Ishigatsubo Y: Esophago-mediastinal and -bronchial fistulas associated with invasive aspergillosis. Endoscopy, 2010, 42 Suppl 2: E48-49.
8. Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda
M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A: The shape of Barrett’s epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol, 2010, 16 (4): 484-489.
9. Akiyama T, Inamori M, Akimoto K, Iida H, Endo H, Hosono K, Ikeda T, Sakamoto
Y, Fujita K, Yoneda M, Koide T, Takahashi H, Tokoro C, Goto A, Abe Y, Kobayashi N, Kubota K, Saito S, Moriya A, Rino Y, Imada T, Nakajima A: Gastric surgery is not a risk factor for erosive esophagitis or Barrett’s esophagus. Scand J Gastroenterol, 2010, 45 (4): 403-408.
10. Sakamoto Y, Inamori M, Iwasaki T, Iida H, Endo H, Hosono K, Ikeda T, Takahashi
H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A: Relationship between upper gastrointestinal symptoms and diet therapy: Examination using frequency scale for the symptoms of GERD.Hepatogastroenterology, 2010, 57 (104): 1635-1638.
11. Tokoro C, Inamori M, Uchiyama T, Iida H, Endo H, Hosono K, Sakamoto Y,
Takahashi H, Koide T, Goto A, Yasuzaki H, Abe Y, Matsuda R, Takahashi D, Kawana I, Suzuki S, Nakajima A: Efficacy of granulocytapheresis (GCAP) for the treatment of active ulcerative colitis and the avoidance of systemic corticosteroid administration. Digestion, 2010, 82 (1): 37-38.
12. Nozaki Y, Oshiro H, Nakajima A: Langerhans cell histiocytosis of the stomach
mimicking early gastric cance. Clin Gastroenterol Hepatol, 2010, 8 (9): A18.
13. Ito S, Oshima A, Inamori M, Uchiyama T, Iida H, Endo H, Hosono K, Sakamoto Y,
Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Kobayashi N, Kubota K, Saito S, Nakajima A: Recurrent sigmoid volvulustreated by colonoscopic reduction. Digestion, 2010, 82 (4): 260.
14. Asano Y, Morita Y, Iguchi K, Kasugai H, Inamori M, Uchiyama T, Iida H, Endo H,
Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Kobayashi N, Kubota K, Nakajima A: Ulcerative colitis with Takayasu disease. Digestion, 2010, 82 (4): 261.
15. Inamori M, Iida H, Hosono K, Endo H, Sakamoto Y, Takahashi H, Koide T, Tokoro
C, Goto A, Abe Y, Hiratsuka N, Nakajima A, Fujita M: The histamine H2 receptor antagonist lafutidine in Japanese patients with nonerosive reflux disease. Hepatogastroenterology, 2010, 57 (104): 1430-1434.
16. Koide T, Inamori M, Kusakabe A, Uchiyama T, Watanabe S, Iida H, Endo H,
Hosono K, Sakamoto Y, Fujita K, Takahashi H, Yoneda M, Tokoro C, Yasuzaki H, Goto A, Abe Y, Kobayashi N, Kubota K, Saito S, Nakajima A: Early complications following percutaneous endoscopic gastrostomy: Results of use of a new direct technique. Hepatogastroenterology 2010 Nov-Dec;57(104):1639-44.
17. Oshima A, Ito S, Abe Y, Uchiyama T, Iida H, Endo H, Hosono K, Sakamoto Y,
Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Inamori M,
Kobayashi N, Kubota K, Saito S, Nakajima A: Mesentric phlebosclerosis. Endoscopy, 2010, 42 Suppl 2: E156-157.
18. Hosono K, Endo H, Takahashi H, Sugiyama M, Uchiyama T, Suzuki K, Nozaki Y,
Yoneda K, Fujita K, Yoneda M, Inamori M, Tomatsu A, Chihara T, Shimpo K, Nakagama H, Nakajima A: Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Molecular Carcinogenesis, 2010, 49 (7): 662-671.
19. Kubota K, Kato S, Mawatari H, Iida H, Akiyama T, Fujita K, Yoneda M, Takahashi
H, Inamori M, Abe Y, Kirikoshi H, Kobayashi N, Saito S, Nakajima A: Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors. Dig Endosc, 2010, 22 (2): 144-146.
20. Nonaka T, Inamori M, Kessoku T, Ogawa Y, Imajyo K, Yanagisawa S, Shiba T,
Sakaguchi T, Nakajima A, Maeda S, Atsukawa K, Takahashi H: A case of acute obstructive cholangitis caused by an enterolith in a duodenal diverticulum. Endoscopy, 2010, 42 Suppl 2: E204-205.
21. Sekino Y, Fujisawa N, Suzuki K, Akimoto K, Tomimoto A, Miharada K, Koyama S,
Iida H, Endo H, Hosono K, Sakamoto Y, Takahashi H, Koide T, Tokoro C, Abe Y, Maeda S, Nakajima A, Tatsumoto A, Sakurada H, Inamori M: A case of recurrent infective endocarditis following colonoscopy. Endoscopy, 2010, 42 Suppl 2: E217.
22. Kato S, Kobayashi N, Kubota K, Kirikoshi H, Watanabe S, Ogawa M, Inamori M,
Shimamura T, Tomeno W, Nakajima A, Takeda K, Endo I, Nagashima Y, Aoki I: A duodenal mucosal lesion coming from pancreatic arteriovenous malformation. Gastrointest Endosc, 2010, 71 (7): 1299-1300.
23. Ito S, Oshima A, Uchiyama T, Maeda S, Nakajima A, Inamori M: Hemolytic
episode following an upper gastrointestinal endoscopy in a patient with paroxysmal nocturnal hemoglobinuria. Dig Endosc, 2010, 23 (1): 99.
24. Uchiyama T, Goto A, sakai e, Sekino Y, Iida H, Endo H, Hosono K, Sakamoto Y,
Koide T, Takahashi H, Yoneda M, Tokoro C, Abe Y, Shimamura T, Kobayashi N, Kubota K, Maeda S, Nakajima A, Ichikawa Y, Inamori M: Endoscopic hemostasis through gastrostomy. Endoscopy, 2010, 42 Suppl 2: E270.
25. Nakajima A, Endo H, Yoneda K, Fujisawa T, Sugiyama M, Hosono K, Nozaki Y,
Takahashi H, Fujita K, Yoneda M, Inamori M, Shimamura T, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Wada K, Nakagama H: Molecular mechanisms linking adiponectin receptor signalling and cancer. The Open Obesity Journal, 2010, 2, 43-49.
26. Kobayashi N, Niwa T, Kirikoshi H, Fujita K, Yoneda M, Saito S, Nakajima A:
Clinical classification of congenital extrahepatic portosystemic shunts. Hepatol Res, 2010, 40 (6): 585-593.
27. Kobayashi N, Kubota K, Kato S, Shimamura T, Kirikoshi H,Saito S, Ueda M, Endo
I, Inayama Y, Nakajima A: FOXP3+ Regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the Pancreas. Pancreatology, 2010, 10 (5): 631-640.
28. Ohtake S, Kobayashi N, Kato S, Kubota K, Endo I, Inayama Y, Nakajima A:
Duodenal gastrointestinal stromal tumor resembling a pancreatic neuroendocrine tumor in a patient with neurofibromatosis type I (von Recklinghausen's disease): a case report. Journal of Medical Case Reports, 2010, 4 (1): 302.
29. Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, Suzuki K,
Iida H, Sakamoto Y, Yoneda K, Koide T, Tokoro C, Abe Y, Inamori M, Nakagama H, Nakajima A: Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila), 2010, 3 (9): 1077-1083.
30. Takahashi H, Hosono K, Uchiyama T, Sugiyama M, Sakai E, Endo H, Maeda S,
Schaefer KL, Nakagama H, Nakajima A: PPARgamma ligand as a promising candidate for colorectal cancer chemoprevention: A Pilot Study. PPAR Res 2010, 2010. pii: 257835. Epub 2010 Aug 2.
31. Kubota K, Nakajima A: The therapeutic strategy for autoimmune pancreatitis is
subject to the endoscopic features of the duodenal papilla. Therap Adv Gastroenterol, 2010, 3 (6): 383-395.
32. Kubota K, Kato S, Watanabe S, Fujita K, Yoneda M, Takahashi H, Inamori M,
Shimamura T, Kirikoshi H, Kobayashi N, Saito S, Hisatomi K, Matsuhashi N, Nakajima A: Usefulness of endoscopic biopsy using FOXP3(+) Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancreatic cancer. J Hepatobiliary Pancreat Sci, 2010 Nov 27. [Epub ahead of print]
✦ InterChange With American soldiers returning from combat in the Middle East, thesubject of post-traumatic stress disorder (PTSD) is in the news. The disorderhas been closely associated with the stress and strain of war, but it’s importantto note that this problem doesn’t just affect veterans, but a surprising numberIn fact, a study by the Veterans Administration (VA) involving the ge
BREAST REDUCTION POSTOPERATIVE INSTRUCTIONS Management of Pain and Discomfort: We have found through many years of experience that the level of pain and discomfort following breast reduction surgery is far less than you might expect. It is not unusual for our patients to return and tell us that their level of discomfort was far less than they had feared. However, you have been given pain reliever